Torrent Pharma net profit declines to Rs 312 crore in Q2
New Delhi: Torrent Pharmaceuticals on Friday reported a marginal decline in its consolidated net profit at Rs 312 crore for the second quarter ended September 2022.
The company had posted a consolidated net profit of Rs 316 crore in the year-ago period.
Revenue from operations rose to Rs 2,291 crore in the July-September quarter as against Rs 2,137 crore in the year-ago period, Torrent Pharma said in a statement.
The company said its domestic revenue stood at Rs 1,224 crore during the period under review.
The drug firm also reported robust sales across various international markets like the US, and Brazil, it added.
Read also: Torrent Pharma to acquire Curatio healthcare for Rs 2,000 crores
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd